Mednet Logo
HomeRheumatologyQuestion

How does the presence of nonalcoholic fatty liver disease (NAFLD) impact your choice of csDMARD for RA?

1
1 Answers
Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Excellent question and one that comes up often in practice. For the sake of discussion, let's assume hepatitis B and C serologies are negative and there is no suspicion of viral hepatitis.

The presence of NAFLD has a direct impact on my choice of csDMARD for RA in this way: if there is significant l...

Register or Sign In to see full answer